Invivyd, Inc. (IVVD) Secures FDA Path for COVID-19 Antibody Approval
Invivyd, Inc. (NASDAQ:IVVD) is a commercial-stage biopharmaceutical company focused on developing antibody-based therapies for serious viral infections, including COVID-19 and influenza.